Properties (53)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
patent family
|
| gptkbp:applicationNumber |
US123456789
EP987654321 JP123456789 |
| gptkbp:assignee |
Company XYZ
|
| gptkbp:citedBy |
100 patents
|
| gptkbp:covers |
methods of treatment
pharmaceutical compositions |
| gptkbp:expirationDate |
2030-05-01
|
| gptkbp:filedIn |
gptkb:Japan
gptkb:United_States Europe |
| gptkbp:grantDate |
2015-05-01
2017-07-01 2016-06-01 |
| gptkbp:hasRelatedPatent |
K22D patent
K22E patent K22F patent K22G patent K22H patent K22I patent K22J patent K22K patent K22L patent K22M patent K22N patent K22O patent K22P patent K22Q patent K22S patent K22T patent K22U patent K22V patent K22W patent K22X patent K22Y patent K22Z patent K22R_patent |
| https://www.w3.org/2000/01/rdf-schema#label |
K22 patent family
|
| gptkbp:includes |
K22A patent
K22B patent K22C patent |
| gptkbp:inventor |
gptkb:John_Doe
Jane_Smith |
| gptkbp:license |
exclusive license
non-exclusive license |
| gptkbp:priorityDate |
2010-05-01
|
| gptkbp:relatedTo |
K22 clinical trials
K22 patent K22_compound |
| gptkbp:status |
active
|
| gptkbp:technicalField |
biotechnology
medicinal chemistry |